This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Dizal (Jiangsu) Pharmaceutical Co., Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Xiaolin Zhang - Innovator in Cyclopentane Compounds
Introduction
Xiaolin Zhang is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of chemistry, particularly in the development of cyclopentane compounds. His work has implications in various medical applications, showcasing the importance of innovation in pharmaceutical research.
Latest Patents
Xiaolin Zhang holds a patent for cyclopentane compounds, which are described in his invention as having a specific formula. The patent details the physical forms of these compounds, the processes for their production, and their potential uses in medicine. This innovation highlights the ongoing need for new chemical compounds in therapeutic applications.
Career Highlights
Throughout his career, Xiaolin Zhang has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Dizal Pharmaceutical Co., Ltd. and Dizal Pharmaceutical Co., Limited. His experience in these organizations has contributed to his expertise in the development of innovative pharmaceutical solutions.
Collaborations
Xiaolin Zhang has collaborated with several professionals in his field, including Weitao Pan and Grigorios Nikitidis. These collaborations have likely enriched his research and development efforts, fostering a collaborative environment for innovation.
Conclusion
Xiaolin Zhang's contributions to the field of cyclopentane compounds exemplify the vital role of inventors in advancing medical science. His patent and career achievements reflect a commitment to innovation that can lead to significant advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile